2024-25 Guide to Medications for the Treatment of Diabetes Mellitus
Likely Readers
The natural reader is radiology trainees, imaging clinicians, sonographers, and diagnostic readers. A casual browser may miss the point; this is more useful when the buyer already has a course, rotation, certification, or clinical problem in mind.
Overview
2024-25 Guide to Medications for the Treatment of Diabetes Mellitus reads as a imaging or diagnostic reference built around pharmacology. That gives it a clearer role than a general survey text.
Subject Focus
- Guideline, policy, or evidence-based material gives the book a useful connection to current practice standards.
Learning Approach
A sensible reading path would start with pharmacology, then branch into the sections that answer the reader’s immediate clinical or academic question.
Editorial Notes
The tone is best approached as professional reference material. It should reward readers who need precise terminology and a clear route back to the subject later.
Book Details
| Author | John R. White PA-C PharmD, Joshua J. Nuemiller PHARMD CDCES FADCES FASCP |
|---|---|
| Publisher | American Diabetes Association |
| Publication Date | July 9, 2024 |
| Language | English |
| Print Length | 682 pages |
| ISBN-10 | 1580408389 |
| ISBN-13 | 978-1580408387 |
| Format | Paperback |
| Dimensions | 6 x 1.38 x 9 inches |
| Item Weight | 15.5 ounces |
Book specifications
Available delivery methods, rates and estimated arrival dates are shown at checkout.
Payment is completed through Shopify's secure checkout.
Delivery availability and final shipping charges are confirmed at checkout. Please review the store policies for return eligibility.